Levobetaxolol hydrochloride: a review of its pharmacology and use in the treatment of chronic open-angle glaucoma and ocular hypertension

References

• AgarwalNMartinEKrishnamoorthyRR2002Levobetaxolol-induced Up-regulation of retinal bFGF and CNTF mRNAs and preservation of retinal function against a photic-induced retinopathyExp Eye Res744455312076088
   PubMed Web of Science ®Google Scholar
• AllenRCHertzmarkEWalzerAM1986A double-masked comparison of betaxolol versus timolol in the treatment of open-angle glaucomaAm J Ophthalmol101535413518464
   PubMed Web of Science ®Google Scholar
• ArendOHarrisAArendS1998The acute effect of topical beta-adrenoreceptor blocking agents on retinal and optic nerve head circulationActa Ophthalmol Scand764399541433
   PubMed Web of Science ®Google Scholar
• BerrospiARLeibowitzHM1982Betaxolol. A new beta-adrenergic blocking agent for treatment of glaucomaArch Ophthalmol10094366124227
   PubMed Web of Science ®Google Scholar
• BerryDPVan BuskirkEMShieldsMB1984Betaxolol and timolol. A comparison of efficacy and side effectsArch Ophthalmol1024256367723
   PubMed Web of Science ®Google Scholar
• CaldwellDRSalisburyCRGuzekJP1984Effects of topical betaxolol in ocular hypertensive patientsArch Ophthalmol102539406704008
   PubMedGoogle Scholar
• CelliniMPossatiGLCaramazzaN1997The use of flunarizine in the management of low-tension glaucoma: a color Doppler studyActa Ophthalmol Scand224Suppl578
   Google Scholar
• ChidlowGMelenaJOsborneNN2000Betaxolol, a beta(1)-adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: comparison with other beta-adrenoceptor antagonistsBr J Pharmacol1307596610864881
   PubMed Web of Science ®Google Scholar
• Coca-PradosMWaxMB1986Transformation of human ciliary epithelial cells by simian virus 40: induction of cell proliferation and retention of beta 2-adrenergic receptorsProc Natl Acad Sci USA83875483022303
   PubMed Web of Science ®Google Scholar
• CriderJYSharifNA2002Adenylyl cyclase activity mediated by beta-adrenoceptors in immortalized human trabecular meshwork and non-pigmented ciliary epithelial cellsJ Ocul Pharmacol Ther182213012099543
   PubMed Web of Science ®Google Scholar
• DranceSM1988A comparison of the effects of betaxolol, timolol, and pilocarpine on visual function in patients with open-angle glaucomaJ Glaucoma7247529713782
   PubMed Web of Science ®Google Scholar
• DranceSM1999Introductory comments on potential differences between β-blockers in the treatment of open-angle glaucomaSurv Ophthalmol43Suppl 1S173S510416760
   PubMed Web of Science ®Google Scholar
• FeghaliJGKaufmanPL1985Decreased intraocular pressure in the hypertensive human eye with betaxolol, a beta 1-adrenergic antagonistAm J Ophthalmol100777822866715
   PubMed Web of Science ®Google Scholar
• FriedmanZBloomEPolanskyJR1999Adrenergic drug effects on cyclic AMP in cultured human trabecular meshwork cellsOphthalmic Res315389831823
   PubMed Web of Science ®Google Scholar
• GoldbergIGoldbergH1995Betaxolol eye drops. A clinical trial of safety and efficacyAust NZ J Ophthalmol231724
   Google Scholar
• HarrisAArendOChungHS2000A comparative study of betaxolol and dorzolamide effect on ocular circulation in normal-tension glaucoma patientsOphthalmology107430410711877
   PubMed Web of Science ®Google Scholar
• HarrisISGreensteinSHBloomAF1986Respiratory difficulties with betaxololAm J Ophthalmol10227453740189
   PubMed Web of Science ®Google Scholar
• HarrisASpaethGLSergottRC1995Retrobulbar arterial hemodynamic effects of betaxolol and timolol in normal-tension glaucomaAm J Ophthalmol120168757639300
   PubMed Web of Science ®Google Scholar
• HenryPJRigbyPJGoldieRG1990Distribution of beta 1- and beta 2-adrenoceptors in mouse trachea and lung: a quantitative autoradiographic studyBr J Pharmacol99136441970491
   PubMed Web of Science ®Google Scholar
• HosteAMSysSU1998Ca2+ channel-blocking activity of propranolol and betaxolol in isolated bovine retinal microarteryJ Cardiovasc Pharmacol3239069733352
   PubMed Web of Science ®Google Scholar
• KaiserHJFlammerJStumpfigD1994Longterm visual field follow-up of glaucoma patients treated with beta-blockersSurv Ophthalmol38SupplS156S97940137
   PubMedGoogle Scholar
• KosekiNAraieMYamagamiJ1999Effects of oral brovincamine on visual field damage in patients with normal-tension glaucoma with low-normal intraocular pressureJ Glaucoma81172310209728
   PubMed Web of Science ®Google Scholar
• KulkarniPSDeSantisL2001Vasorelaxant effects of racemic betaxolol and its R- and S-isomers on bovine retinal vesselsJ Glaucoma10423611711842
   PubMed Web of Science ®Google Scholar
• Le JeunneCMuneraYHuguesFC1990Systemic effects of three beta-blocker eyedrops: comparison in healthy volunteers of beta 1- and beta 2-adrenoreceptor inhibitionClin Pharmacol Ther47578831971539
   PubMed Web of Science ®Google Scholar
• LongDAJohnsGEMullenRS1988Levobunolol and betaxolol. A double-masked controlled comparison of efficacy and safety in patients with elevated intraocular pressureOphthalmology95735413062529
   PubMed Web of Science ®Google Scholar
• MelenaJStantonDOsborneNN2001Comparative effects of antiglaucoma drugs on voltage-dependent calcium channelsGraefes Arch Clin Exp Ophthalmol2395223011521697
   PubMed Web of Science ®Google Scholar
• MelenaJWoodJPOsborneNN1999Betaxolol, a beta1-adrenoceptor antagonist, has an affinity for L-type Ca2+ channelsEur J Pharmacol3783172210493108
   PubMed Web of Science ®Google Scholar
• MessmerCFlammerJStumpfigD1991Influence of betaxolol and timolol on the visual fields of patients with glaucomaAm J Ophthalmol112678811957903
   PubMed Web of Science ®Google Scholar
• NathansonJA1981Human ciliary process adrenergic receptor: pharmacological characterizationInvest Ophthalmol Vis Sci217988046118346
   PubMed Web of Science ®Google Scholar
• NathansonJA1988Stereospecificity of beta adrenergic antagonists: R-enantiomers show increased selectivity for beta-2 receptors in ciliary processJ Pharmacol Exp Ther245941012896241
   PubMed Web of Science ®Google Scholar
• NeufeldAH1978Influences of cyclic nucleotides on outflow facility in the vervet monkeyExp Eye Res2738797215426
   PubMed Web of Science ®Google Scholar
• NeufeldAHDuekerDKVeggeT1975Adenosine 3′,5′-monophosphate increases the outflow of aqueous humor from the rabbit eyeInvest Ophthalmol Vis Sci14402
   Google Scholar
• NeufeldAHJampolLMSearsML1972Cyclic-AMP in the aqueous humor: the effects of adrenergic agentsExp Eye Res14242504344979
   PubMed Web of Science ®Google Scholar
• OkisakaSKuwabaraT1974Selective destruction of the pigmented epithelium in the ciliary body of the eyeScience184129894208491
   PubMed Web of Science ®Google Scholar
• OsborneNNWoodJPChidlowG2004Effectiveness of levobetaxolol and timolol at blunting retinal ischaemia is related to their calcium and sodium blocking activities: relevance to glaucomaBrain Res Bull62525815036567
   PubMed Web of Science ®Google Scholar
• PhanTMNguyenKPGiacominiJC1991Ophthalmic beta-blockers: determination of plasma and aqueous humor levels by a radioreceptor assay following multiple dosesJ Ocul Pharmacol7243521686051
   PubMedGoogle Scholar
• QuarantaLGandolfoFTuranoR2006Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure inpatients with glaucomaInvest Ophthalmol Vis Sci4729172316799034
   PubMed Web of Science ®Google Scholar
• RadiusRL1983Use of betaxolol in the reduction of elevated intraocular pressureArch Ophthalmol1018989006860201
   PubMedGoogle Scholar
• ReissGRBrubakerRF1983The mechanism of action of betaxolol, a new ocular hypotensive agentOphthalmology901369726664677
   PubMed Web of Science ®Google Scholar
• RoholtPC1987Betaxolol and restrictive airway disease. Case reportArch Ophthalmol10511723632433
   PubMedGoogle Scholar
• RuggELBarnettDBNahorskiSR1978Coexistence of beta1 and beta2 adrenoceptors in mammalian lung: evidence from direct binding studiesMol Pharmacol14996100532480
   PubMed Web of Science ®Google Scholar
• SatohENarimatsuAHosohataY1993The affinity of betaxolol, a beta 1-adrenoceptor-selective blocking agent, for beta-adrenoceptors in the bovine trachea and heartBr J Pharmacol10848498383566
   PubMed Web of Science ®Google Scholar
• SchoeneRBAbuanTWardRL1984Effects of topical betaxolol, timolol, and placebo on pulmonary function in asthmatic bronchitisAm J Ophthalmol9786926141730
   PubMed Web of Science ®Google Scholar
• SearsM1984Pharmacology of the eyeNew YorkSpringer
   Google Scholar
• SharifNAXuSX2004Binding affinities of ocular hypotensive beta-blockers levobetaxolol, levobunolol, and timolol at endogenous guinea pig beta-adrenoceptorsJ Ocul Pharmacol Ther2093915117564
   PubMed Web of Science ®Google Scholar
• SharifNAXuSXCriderJY2001Levobetaxolol (Betaxon) and other beta-adrenergic antagonists: preclinical pharmacology, IOP-lowering activity and sites of action in human eyesJ Ocul Pharmacol Ther173051711572462
   PubMed Web of Science ®Google Scholar
• SteigerwaltRDJrLauroraGBelcaroGV2001Ocular and retrobulbar blood flow in ocular hypertensives treated with topical timolol, betaxolol and carteololJ Ocul Pharmacol Ther175374411777177
   PubMed Web of Science ®Google Scholar
• StewartRHKimbroughRLWardRI1986Betaxolol versus timolol. A six-month double-blind comparisonArch Ophthalmol1044683510612
   PubMed Web of Science ®Google Scholar
• TownsendDJBrubakerRF1980Immediate effect of epinephrine on aqueous formation in the normal human eye as measured by fluorophotometryInvest Ophthalmol Vis Sci19256667358476
   PubMed Web of Science ®Google Scholar
• TuracliMEOzdenRGGursesMA1988The effect of betaxolol on ocular blood flow and visual fields in patients with normotension glaucomaEur J Ophthalmol86269673472
   PubMed Web of Science ®Google Scholar
• Van BuskirkEM1980Adverse reactions from timolol administrationOphthalmology87447507402590
   PubMed Web of Science ®Google Scholar
• Van BuskirkEMWeinrebRNBerryDP1986Betaxolol in patients with glaucoma and asthmaAm J Ophthalmol10153143706457
   PubMed Web of Science ®Google Scholar
• WaxMBMolinoffPB1987Distribution and properties of beta-adrenergic receptors in human iris-ciliary bodyInvest Ophthalmol Vis Sci28420303030954
   PubMed Web of Science ®Google Scholar
• WeinrebRNCaldwellDRGoodeSM1990A double-masked three-month comparison between 0.25% betaxolol suspension and 0.5% betaxolol ophthalmic solutionAm J Opthalmol11018992
   PubMed Web of Science ®Google Scholar
• WeinrebRNJaniR1992A novel formulation of an ophthalmic beta-adrenoreceptor antagonistJ Parenter Sci Technol465131588458
   PubMedGoogle Scholar
• WeinrebRNVan BuskirkEMCherniackK1988Long-term betaxolol therapy in glaucoma patients with pulmonary diseaseAm J Ophthalmol10616273400758
   PubMed Web of Science ®Google Scholar
• WiederholtM1998Direct involvement of trabecular meshwork in the regulation of aqueous humor outflowCurr Opin Ophthalmol946910180513
   PubMedGoogle Scholar
• YamadaYTakayanagiRTsuchiyaK2001Assessment of systemic aderse reactions induced by ophthalmic beta-adrenergic receptor antagonistsJ Ocul Pharmacol Ther172354811436944
   PubMed Web of Science ®Google Scholar
• YarangümeliAKuralG2004Are there any benefits of Betoptic S (betaxolol HCl ophthalmic suspension) over other beta-blockers in the treatment of glaucoma?Expert Opin Pharmacother510718115155109
   PubMed Web of Science ®Google Scholar
• YoshidaAOgasawaraHFujioN1998Comparison of short- and long-term effects of betaxolol and timolol on human retinal circulationEye128485310070522
   PubMed Web of Science ®Google Scholar